KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea
· Delayed Price · Currency is KRW 12,130
-610 (-4.79%)
At close: Mar 9, 2026
KOREA PHARMA Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 132,298 | 166,982 | 257,943 | 233,403 | 529,520 | 242,129 | Upgrade
|
| Market Cap Growth | -21.49% | -35.26% | 10.51% | -55.92% | 118.69% | - | Upgrade
|
| Enterprise Value | 137,108 | 151,067 | 248,815 | 222,946 | 528,191 | 235,248 | Upgrade
|
| Last Close Price | 12130.00 | 15251.21 | 23482.14 | 21200.57 | 47987.24 | 21920.01 | Upgrade
|
| PE Ratio | 759.66 | 44.04 | 3079.40 | - | 83.15 | 76.65 | Upgrade
|
| Forward PE | - | 82.10 | 82.10 | 82.10 | 112.13 | 39.78 | Upgrade
|
| PS Ratio | 1.47 | 2.05 | 3.10 | 2.88 | 6.65 | 3.39 | Upgrade
|
| PB Ratio | 1.86 | 2.34 | 3.76 | 3.90 | 9.21 | 5.21 | Upgrade
|
| P/TBV Ratio | 1.96 | 2.48 | 3.96 | 4.10 | 9.72 | 5.50 | Upgrade
|
| P/FCF Ratio | - | 34.81 | 78.44 | 40.14 | 114.12 | - | Upgrade
|
| P/OCF Ratio | 25.12 | 20.75 | 53.52 | 28.19 | 73.62 | - | Upgrade
|
| EV/Sales Ratio | 1.52 | 1.86 | 2.99 | 2.75 | 6.64 | 3.29 | Upgrade
|
| EV/EBITDA Ratio | 17.14 | 17.01 | 28.75 | 26.02 | 71.46 | 34.47 | Upgrade
|
| EV/EBIT Ratio | 27.98 | 24.82 | 42.60 | 36.03 | 105.34 | 51.10 | Upgrade
|
| EV/FCF Ratio | -8.31 | 31.49 | 75.67 | 38.34 | 113.83 | - | Upgrade
|
| Debt / Equity Ratio | 0.54 | 0.32 | 0.51 | 0.91 | 0.94 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 5.93 | 2.58 | 4.03 | 6.38 | 7.27 | 2.04 | Upgrade
|
| Debt / FCF Ratio | - | 4.77 | 10.60 | 9.40 | 11.58 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.07 | -0.21 | -0.20 | -0.14 | -0.15 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.75 | -1.66 | -1.55 | -0.99 | -1.19 | -0.72 | Upgrade
|
| Net Debt / FCF Ratio | -0.29 | -3.08 | -4.09 | -1.45 | -1.90 | 1.73 | Upgrade
|
| Asset Turnover | 0.75 | 0.70 | 0.66 | 0.62 | 0.76 | 0.97 | Upgrade
|
| Inventory Turnover | 2.59 | 2.46 | 2.59 | 2.67 | 2.40 | 2.30 | Upgrade
|
| Quick Ratio | 1.17 | 2.76 | 1.89 | 1.14 | 3.13 | 1.13 | Upgrade
|
| Current Ratio | 1.70 | 3.81 | 2.56 | 1.41 | 3.81 | 1.79 | Upgrade
|
| Return on Equity (ROE) | 0.24% | 5.42% | 0.13% | -1.91% | 12.25% | 8.64% | Upgrade
|
| Return on Assets (ROA) | 1.74% | 3.26% | 2.89% | 2.97% | 2.97% | 3.89% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.34% | 10.57% | 0.46% | 12.37% | 11.11% | 10.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 6.50% | 6.60% | 10.10% | 4.80% | 9.10% | Upgrade
|
| Earnings Yield | 0.13% | 2.27% | 0.03% | -0.48% | 1.20% | 1.31% | Upgrade
|
| FCF Yield | -12.47% | 2.87% | 1.27% | 2.49% | 0.88% | -1.18% | Upgrade
|
| Payout Ratio | 313.13% | 14.38% | 651.04% | - | 8.56% | 13.91% | Upgrade
|
| Buyback Yield / Dilution | -15.73% | -15.33% | 3.63% | 1.22% | -12.80% | -10.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.